Loading clinical trials...
Loading clinical trials...
A Phase 2 Open-Label, Parallel Group, Randomized, Dose-Finding Study to Assess the Efficacy and Safety of Intercostal SKY0402 in Subjects Undergoing Posterolateral Thoracotomy
Conditions
Interventions
Low Dose SKY0402
High Dose SKY0402
+3 more
Locations
5
United States
Lotus Clinical Research
Pasadena, California, United States
Florida Hospital
Orlando, Florida, United States
Memorial Hermann - Memorial City Medical Center
Houston, Texas, United States
Houston NW Medical Center
Houston, Texas, United States
Multicare Health System
Tacoma, Washington, United States
Start Date
December 1, 2008
Primary Completion Date
February 1, 2009
Completion Date
February 1, 2009
Last Updated
May 15, 2012
NCT06862609
NCT07436806
NCT07327463
NCT07442721
NCT07440940
NCT07413055
Lead Sponsor
Pacira Pharmaceuticals, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions